首页> 外文期刊>The Journal of neuroscience nursing: journal of the American Association of Neuroscience Nurses >A Pilot Randomized Controlled Trial Testing the Feasibility and Acceptability of a SystemCHANGE Intervention to Improve Medication Adherence in Older Adult Stroke Survivors
【24h】

A Pilot Randomized Controlled Trial Testing the Feasibility and Acceptability of a SystemCHANGE Intervention to Improve Medication Adherence in Older Adult Stroke Survivors

机译:试点随机对照试验测试系统化干预的可行性和可接受性,以改善老年人中风幸存者中的药物粘附

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Adhering to an antithrombotic medication regimen is essential to reducing recurrent stroke in adult stroke survivors. The purpose of this study was to evaluate the feasibility and acceptability of the SystemCHANGE (SC) and attention control (AC) intervention in older adult, nonadherent ischemic stroke patients. METHODS: A pilot randomized controlled trial was conducted to determine the feasibility and acceptability of an SC versus AC intervention in older adult, nonadherent stroke survivors in the management of antithrombotic medication. Participants were masked to group assignment. Stroke survivors 50 years or older, taking at least 1 once-a-day antithrombotic medication, were recruited from a Midwest Comprehensive Stroke Center-affiliated neurology office. They were screened electronically using the Medication Event Monitoring System for 2 months to determine baseline medication adherence. Nonadherent stroke survivors (medication adherence < 0.97) were randomized to SC or AC intervention and monitored for 3 months. SC focused on redesigning the interpersonal environmental system and daily routines. The AC group was provided education materials on stroke that consisted of stroke risk factor reduction, stroke facts, rehabilitation, and nutrition with the primary investigator. Participation and intervention experience interviews were evaluated for themes. RESULTS: Thirty participants were recruited: median age was 64 years, 46.7% of them were male, and they took an average of 7.77 (SD, 3.191; range, 3-15) prescribed medications. The number of over-the-counter medications taken (excluding aspirin) on a regular basis averaged 1.9 (SD, 0.8; range, 1-4). Two participants were nonadherent and were randomized to the 2 arms. Both participants had positive feedback and were not inconvenienced by their participation in the study. Neither participant voiced concerns about the intervention, survey demands, time requirement, or completing the surveys on the primary investigator's laptop. CONCLUSION: The SC and AC intervention protocols were feasible and acceptable to the participants in this study. Additional pilot testing is needed to further evaluate the intervention and its effect on medication adherence in this population.
机译:背景:遵守抗血栓形成药物方案对于减少成人中风幸存者中的复发性卒中至关重要。本研究的目的是评估较老成人,非抗震缺血性脑卒中患者的系统化(SC)和注意力控制(AC)干预的可行性和可接受性。方法:进行试点随机对照试验,以确定抗血栓组合管理中老年人的SC与AC干预的可行性和可接受性。参与者被屏蔽了组分配。从中西部综合中风中心隶属神经病学办公室招募了50岁或以上的中风幸存者,占用了至少1例一次抗血栓性药物。它们使用药物事件监测系统以电子方式筛选2个月以确定基线药物依从性。非恋卒中幸存者(药物粘附<0.97)被随机分配到SC或AC干预并监测3个月。 SC专注于重新设计人际关系环境系统和日常生活。 AC集团为卒中提供教育材料,包括卒中危险因素减少,中风事实,康复和营养与主要调查员为组成。对主题评估了参与和干预经验的访谈。结果:招聘了三十名参与者:中位年龄为64岁,其中46.7%是男性,平均花了7.77(SD,3.191;范围,3-15)规定的药物。 (不包括阿司匹林)的过度计量药物的数量平均为1.9(SD,0.8;范围,1-4)。两个参与者是非恋的,并随机随机分为2个武器。这两个参与者都有积极的反馈,并没有对该研究的参与不方便。与参与者有任何参与者对干预,调查要求,时间要求或在主要调查员笔记本电脑上进行调查。结论:本研究中的参与者可行和可接受的SC和AC干预协议是可行的。需要额外的试验测试来进一步评估干预措施及其对本人的药物依从性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号